Article info
Clinical and epidemiological research
Extended report
The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritis
- Correspondence to Dr Vivian P Bykerk, Hospital for Special Surgery, 535 East 70th St., New York, NY 10021, USA; bykerkv{at}hss.edu
Citation
The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritis
Publication history
- Received August 19, 2014
- Revised March 4, 2015
- Accepted April 5, 2015
- First published May 15, 2015.
Online issue publication
December 29, 2022
Article Versions
- Previous version (29 December 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/